MARKET WIREYahoo Finance • 9h ago
Why The Ensign Group (ENSG) stock is up todayYahoo Finance report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
Why ENSG Stock dropped -2.58% Today — RQD Quant Desk Flash
$181.52 -2.58% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $181.11
The Ensign Group Inc. (ENSG) earns a Roarable Rating of B (Buy) with 72/100 RQD Confidence. High-quality cash engine (20% profit margin, 18% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE B • BUY
Cap $10.87B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on ENSG Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is ENSG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, The Ensign Group Inc. (NASDAQ: ENSG) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $181.52 (-2.58% 1D, market cap $10.87B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, ENSG ranks #67 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does ENSG compare to UHS and EHC in the Health Care sector?
▼
Within the Health Care sector (Hospital/Nursing Management), ENSG carries a Roarable B (72/100 RQD), trailing P/E of 31.6x, gross margin of 20.1%, and ROIC of 18.0%. By comparison, UHS (Universal Health Services Inc.) holds a C grade (63/100 RQD, P/E 7.0x, ROIC 14.1%, cap $10.41B) and EHC (Encompass Health Corporation) posts a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for ENSG?
▼
Per ENSG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001125376), The Ensign Group Inc. generated $5.03B in revenue (+18.8% YoY), $344.0M in net income, and $337.8M in free cash flow against $5.46B in total assets and $137.5M in total debt. Key quantitative strengths: Strong cash generator (20% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $181.12 (-0.22%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 6.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 72/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.0% avg 90D alpha vs SPY • 68.7% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • B
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+6.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ENSG)Realized 20D OHLCV Swing Band: ±5.4%
Deterministic 5-Pillar Attribution (72/100 Composite)
🔍 WHY ENSG SCORES 72/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+17/20 pts (24% of score)
SEC XBRL FY 2025 (10-K): 6.7% FCF Margin ($337.8M FCF) & 20.1% Gross Margin
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (22% of score)
Altman Z-Score 3.73 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution13/20 pts (-7 pt drag)
Cannibal Buyback (-1.52% YoY Shares) & executive Form 4 sales trim 7 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C+$173.26+1.6% Next Q
64
Q2 (-2Q)Grade B-$176.00-3.7% Next Q
67
Q3 (-1Q)Grade B-$169.50+7.1% Next Q
69
CurrentGrade B$181.52+7% Hist 90D α
72
Trajectory: C+ (64) → B (72)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the ENSG Bull Thesis Could Fail
Even with a 72/100 (B) score, ENSG faces multiple-compression risk if 31.6x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 17.6% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($175.06) or 200D SMA ($181.68) invalidates the momentum regime and cuts Target Base ($192.96) toward Bear Floor ($148.85).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ENSG• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ENSG Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ENSG Stock dropped -2.58% Today — RQD Quant Desk Flash
The Ensign Group Inc. (ENSG) dropped -2.58% to $181.52, trading at 52% of its 52-week range ($141.58 – $218). High-quality cash engine (20% profit margin, 18% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 52% of its 52-week range ($141.58 – $218) with RSI-14 at 60.2 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±5.4% around $181.52 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 20.1% gross margin and $337.8M annual free cash flow.
Live ENSG Headlines & Catalysts
MARKET WIREMorningstar • 12h ago
Shareholders who lost money in shares of acquired The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein ImmediatelyMorningstar report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
MARKET WIREThe Globe and Mail • 15h ago
The Ensign Group (ENSG) to report earnings tomorrow: here is what to expectThe Globe and Mail report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeeking Alpha • 18h ago
The Ensign Group Is Healthy, But Not Worth Buying (NASDAQ:ENSG)Seeking Alpha report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 21h ago
The Ensign Group, Inc. Estimates – NASDAQ:ENSGTradingView report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESimply Wall St • 1d ago
Ensign Group (Nasdaq:ENSG) - Stock AnalysisSimply Wall St report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Ensign Group (ENSG) Stock May Be Near Fair Value On Cash FlowYahoo Finance report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
RISK WATCHMorningstar • 1d ago
Investor Alert: Ensign Group (ENSG) has been Sued for Securities Fraud Over Alleged Misstatements made to InvestorsMorningstar report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo • 2d ago
ENSG Q3 deep dive: organic growth and acquisitions drive occupancy and margin gainsHealthcare services company The Ensign Group (NASDAQ:ENSG) fell short of the market’s revenue expectations in Q3 2026, but sales rose 14.5% year on year to $1.48 billion. On the other hand, the company’s outlook for the
RISK WATCHYahoo • 3d ago
The 5 most interesting analyst questions from The Ensign Group’s Q3 earnings callThe Ensign Group’s third quarter drew a positive market reaction despite missing Wall Street’s revenue and earnings per share expectations, as investors looked beyond headline numbers to underlying business momentum. Man
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (ENSG Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ENSG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -0.28%▲ ASCENDING TRIANGLE
2026-11-02O $184.1H $186.3L $181.5C $181.5VOL 465.5K
RES: $189.1SUP: $169.8SMA50: $175.1SMA200: $181.7
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ENSG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
24.4%/yr Implied 5Y Growth
vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ENSG today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ENSG. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ENSG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ENSG)
Health Care Rank #67 of 1016
⚔️ UHS vs ENSG Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ENSG vs. UHS, EHC, PACS, THC)
Industry: Hospital/Nursing Management (14 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, The Ensign Group Inc. (ENSG) ranks #67 by composite RQD confidence (72/100, grade B) and #103 by equity capitalization ($10.87B). Within this direct 5-issuer industry benchmark cohort, UHS leads on earnings valuation at 7.0x trailing P/E, while THC leads on capital efficiency and profitability with 27.6% ROIC and — gross margin. EHC currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with ENSG at 72/100 (B).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ENSG
ACTIVE
The Ensign Group Inc. | B | 72/100 | 31.6x | 20.1% | 18.0% | -2.58% | $10.87B | Benchmark Subject |
| UHS Universal Health Services Inc. | C | 63/100 | 7.0x | — | 14.1% | -0.32% | $10.41B | /uhs-vs-ensg → |
| EHC Encompass Health Corporation | B+ | 77/100 | 22.9x | — | 13.8% | +3.35% | $12.97B | /ehc-vs-ensg → |
| PACS PACS Group Inc. | B | 74/100 | 41.1x | — | 24.6% | -3.76% | $7.87B | /pacs-vs-ensg → |
| THC Tenet Healthcare Corporation | B | 74/100 | 9.2x | — | 27.6% | +0.99% | $21.79B | /thc-vs-ensg → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001125376In its most recent audited fiscal period (FY2025, filed 2025-12-31), The Ensign Group Inc. (ENSG) reported GAAP revenue of $5.03B (+18.8% vs. FY2024 revenue of $4.24B , and +35.7% cumulative change since FY2023) , GAAP net income of $344.0M, operating cash flow of $564.3M, and free cash flow of $337.8M (+115.9% YoY). On the balance sheet, ENSG closed FY2025 with $5.46B in total assets against $137.5M in total debt (Altman Z-Score: 3.73, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $5.03B | $344.0M | $564.3M | $337.8M | $5.46B | $137.5M |
| FY2024 (FY) | 2024-12-31 | $4.24B | $298.0M | $347.2M | $156.5M | $4.67B | $141.6M |
| FY2023 (FY) | 2023-12-31 | $3.71B | $209.4M | $376.7M | $209.8M | $5.98B | $1.40B |
3. ENSG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ENSG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, The Ensign Group Inc. (NASDAQ: ENSG) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $181.52 (-2.58% 1D, market cap $10.87B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, ENSG ranks #67 in composite RQD confidence.
How does ENSG compare to UHS and EHC in the Health Care sector?
Within the Health Care sector (Hospital/Nursing Management), ENSG carries a Roarable B (72/100 RQD), trailing P/E of 31.6x, gross margin of 20.1%, and ROIC of 18.0%. By comparison, UHS (Universal Health Services Inc.) holds a C grade (63/100 RQD, P/E 7.0x, ROIC 14.1%, cap $10.41B) and EHC (Encompass Health Corporation) posts a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ENSG?
Per ENSG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001125376), The Ensign Group Inc. generated $5.03B in revenue (+18.8% YoY), $344.0M in net income, and $337.8M in free cash flow against $5.46B in total assets and $137.5M in total debt. Key quantitative strengths: Strong cash generator (20% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ENSG trading relative to its 50-day, 200-day, and 52-week technical levels?
ENSG last traded at $181.52 (-2.58% on volume of 411,720 shares), positioning the stock +3.69% above its 50-day simple moving average ($175.06) and -0.09% below its 200-day simple moving average ($181.68). Across its 52-week range of $141.58 to $218.00, ENSG sits at the 52.3% percentile with a 14-day RSI of 60.2 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.4% ($171.72 to $191.32).
ENSG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ENSG stock moving today?
Why ENSG Stock dropped -2.58% Today — RQD Quant Desk Flash. High-quality cash engine (20% profit margin, 18% return on capital) with steady institutional support.
ROARABLE RATING BRIEF • RQD 72/100 (B)
✓ STAGE-C NUMBER FIREWALL VERIFIED
ENSG — The Ensign Group Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:16:11Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, ENSG scores 72 out of 100, grade B, labeled "Roarable Buy — Good Risk/Reward." The five pillars are: Fundamental Cash Engine 17/20 (ROIC 18%; FCF yield 3.11%); Whale 13F Flow 13/20 (institutional accumulation and options positioning); Insider Conviction 13/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit 13/20 (Beta 0.89; sector sensitivity); and Forensic Balance Sheet 16/20 (Altman Z 3.73; Piotroski F 8/9; Debt/Equity 0.06).
For a prospective investor, the strongest pillar is the cash engine, which pairs an 18% ROIC with a 3.11% FCF yield, suggesting the business generates meaningful returns on capital. The balance-sheet pillar is also strong, with low leverage (Debt/Equity 0.06) and high Piotroski and Altman readings. The middle pillars (institutional flow, insider flow, macro fit) are moderate, indicating neither a strong accumulation signal nor a clear macro headwind. Valuation is a tradeoff: the trailing P/E of 31.6 and EV/EBITDA of 17 are elevated relative to the forward P/E of 26.5, meaning the price already embeds expectations of earnings growth. The stock's 52-week range of $141.58 – $218 places the current price of $186.32 in the upper portion of that band. The rating is a quantitative summary of the cited inputs, not personalized advice.
Snapshot
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 (filed 2025-12-31) | $5032.1M | $425.3M | $344.0M | N/A | $337.8M | $503.9M | $137.5M |
| FY 2024 (filed 2024-12-31) | $4237.5M | $358.3M | $298.0M | N/A | $156.5M | $464.6M | $141.6M |
| FY 2023 (filed 2023-12-31) | $3708.1M | $255.4M | $209.4M | N/A | $209.8M | N/A | $1399.0M |
Revenue grew from $3708.1M (FY 2023) to $5032.1M (FY 2025), and net income rose from $209.4M to $344.0M over the same span. Per the market data, gross margin is 20.1%, operating margin 8.5%, and net margin 6.8%. ROIC is 18%, and the Roarable forensic metrics report an Altman Z-Score of 3.73 and a Piotroski F-Score of 8/9. Debt/Equity is 0.06 per the RQD forensic pillar. Reported debt fell from $1399.0M (FY 2023) to $137.5M (FY 2025), while cash was $503.9M at FY 2025.
Open Questions
- What are the specific revenue drivers and payer mix behind the FY 2025 revenue increase to $5032.1M?
- What did the company report in its upcoming earnings event, and how do results compare with the estimates referenced in the news feed?
- Why is EPS reported as N/A for all three periods, and what is the reconciled per-share earnings history?
- What explains the sharp reduction in reported debt from $1399.0M (FY 2023) to $137.5M (FY 2025), and what is the current debt maturity schedule?
- What is the nature of the shareholder-rights notice referenced in the Morningstar headline?
ENSG Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for The Ensign Group Inc. (ENSG) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 9h ago
Why The Ensign Group (ENSG) stock is up today Yahoo Finance report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Morningstar • 12h ago
Shareholders who lost money in shares of acquired The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately Morningstar report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE The Globe and Mail • 15h ago
The Ensign Group (ENSG) to report earnings tomorrow: here is what to expect The Globe and Mail report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 18h ago
The Ensign Group Is Healthy, But Not Worth Buying (NASDAQ:ENSG) Seeking Alpha report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 21h ago
The Ensign Group, Inc. Estimates – NASDAQ:ENSG TradingView report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall St • 1d ago
Ensign Group (Nasdaq:ENSG) - Stock Analysis Simply Wall St report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Ensign Group (ENSG) Stock May Be Near Fair Value On Cash Flow Yahoo Finance report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Morningstar • 1d ago
Investor Alert: Ensign Group (ENSG) has been Sued for Securities Fraud Over Alleged Misstatements made to Investors Morningstar report covering The Ensign Group Inc. (ENSG) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
ENSG Bull vs. Bear Conversation Board — What's Your Call at $181.52?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ENSG 🐻 33% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH
🎯 Target: $219.86 (+18.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is ENSG (B • RQD 72/100) a Buy at $186.32?
Welcome to the ENSG (The Ensign Group Inc.) Roar Pit. Current RQD Composite is 72/100 (Roarable Buy — Good Risk/Reward) in Hospital/Nursing Management. Bulls point to capital efficiency (18.0% ROIC), while bears focus on valuation multiple compression (31.6x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
FO ForensicBear Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $141.60 (-24.0%)
Spot @ $186.32 Pump the brakes on ENSG — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on ENSG, but look at what you are paying: 31.6x trailing P/E with 20.1% gross margins. Unless The Ensign Group Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH
🎯 Target: $227.31 (+22.0%)
Spot @ $186.32 ENSG cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on ENSG, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $186.32 (52-wk range $141.58 - $218.00), any beat on forward guidance forces shorts and underweight funds to chase.